KNTE Shares Outstanding History



Below is a table of the KNTE shares outstanding history going back to 12/3/2020:

Date KNTE Shares Outstanding
12/3/202041.03M
3/26/202143.48M
5/10/202143.50M
8/10/202143.68M
11/9/202143.70M
3/25/202243.95M
5/9/202243.98M
11/7/202244.16M
3/10/202346.57M
5/8/202346.57M
8/4/202347.09M
11/3/202347.11M

Also see: KNTE Market Cap History
KNTE YTD Return
KNTE Historical Shares Outstanding:
+4.86% CAGR
KNTE Historical Shares Outstanding: +4.86% CAGR

Mouse over chart for data details
12/3/2020 ...11/3/2023
Kinnate is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for genomically defined cancers. Co.'s focus is on three patient populations: those with cancers that harbor known oncogenic drivers with no available targeted therapies; those with genomically well-characterized tumors that have resistance to available treatments; and those whose tumors have acquired resistance over the course of therapy to available treatments. Co.'s product candidates are KIN002787, which is for the treatment of patients with lung cancer, melanoma and other solid tumors; and KIN-3248, which is targeting cancer-associated alterations in FGFR2. We show 12 historical shares outstanding datapoints in our coverage of KNTE's shares outstanding history.

Understanding the changing numbers of KNTE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KNTE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KNTE by allowing them to research KNTE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree KNTE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Kinnate Biopharma (KNTE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

KOD Shares Outstanding History
KOOL Shares Outstanding History
KPRX Shares Outstanding History
KPTI Shares Outstanding History
KRBP Shares Outstanding History
KRMD Shares Outstanding History
KRON Shares Outstanding History
KROS Shares Outstanding History
KRRO Shares Outstanding History
KRTX Shares Outstanding History
More Healthcare companies »

 

KNTE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.